BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 30935395)

  • 1. Correction to: LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway.
    Liu B; Pan S; Xiao Y; Liu Q; Xu J; Jia L
    J Exp Clin Cancer Res; 2019 Apr; 38(1):142. PubMed ID: 30935395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction to: LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway.
    Liu B; Pan S; Xiao Y; Liu Q; Xu J; Jia L
    J Exp Clin Cancer Res; 2019 Aug; 38(1):367. PubMed ID: 31431194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway.
    Liu B; Pan S; Xiao Y; Liu Q; Xu J; Jia L
    J Exp Clin Cancer Res; 2018 Dec; 37(1):316. PubMed ID: 30547804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
    Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
    Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-26a promoted endometrial epithelium cells (EECs) proliferation and induced stromal cells (ESCs) apoptosis via the PTEN-PI3K/AKT pathway in dairy goats.
    Zhang L; Liu X; Liu J; Ma X; Zhou Z; Song Y; Cao B
    J Cell Physiol; 2018 Jun; 233(6):4688-4706. PubMed ID: 29115668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-26a suppresses recruitment of macrophages by down-regulating macrophage colony-stimulating factor expression through the PI3K/Akt pathway in hepatocellular carcinoma.
    Chai ZT; Zhu XD; Ao JY; Wang WQ; Gao DM; Kong J; Zhang N; Zhang YY; Ye BG; Ma DN; Cai H; Sun HC
    J Hematol Oncol; 2015 May; 8():56. PubMed ID: 26021873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HOTAIR/miR-326/FUT6 axis facilitates colorectal cancer progression through regulating fucosylation of CD44 via PI3K/AKT/mTOR pathway.
    Pan S; Liu Y; Liu Q; Xiao Y; Liu B; Ren X; Qi X; Zhou H; Zeng C; Jia L
    Biochim Biophys Acta Mol Cell Res; 2019 May; 1866(5):750-760. PubMed ID: 30742932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-204 modulates colorectal cancer cell sensitivity in response to 5-fluorouracil-based treatment by targeting high mobility group protein A2.
    Wu H; Liang Y; Shen L; Shen L
    Biol Open; 2016 May; 5(5):563-70. PubMed ID: 27095441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-26a involved in Toll-like receptor 9‑mediated lung cancer growth and migration.
    Jiang DS; Wang YW; Jiang J; Li SM; Liang SZ; Fang HY
    Int J Mol Med; 2014 Jul; 34(1):307-12. PubMed ID: 24788552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioma stem cells-derived exosomal miR-26a promotes angiogenesis of microvessel endothelial cells in glioma.
    Wang ZF; Liao F; Wu H; Dai J
    J Exp Clin Cancer Res; 2019 May; 38(1):201. PubMed ID: 31101062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer.
    Li Y; Sun Z; Liu B; Shan Y; Zhao L; Jia L
    Cell Death Dis; 2017 Jun; 8(6):e2892. PubMed ID: 28640257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-26a downregulates retinoblastoma in colorectal cancer.
    López-Urrutia E; Coronel-Hernández J; García-Castillo V; Contreras-Romero C; Martínez-Gutierrez A; Estrada-Galicia D; Terrazas LI; López-Camarillo C; Maldonado-Martínez H; Jacobo-Herrera N; Pérez-Plasencia C
    Tumour Biol; 2017 Apr; 39(4):1010428317695945. PubMed ID: 28443472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN.
    Liu B; Wu X; Liu B; Wang C; Liu Y; Zhou Q; Xu K
    Biochim Biophys Acta; 2012 Nov; 1822(11):1692-704. PubMed ID: 22885155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-26a and miR-26b mediate osteoarthritis progression by targeting FUT4 via NF-κB signaling pathway.
    Hu J; Wang Z; Pan Y; Ma J; Miao X; Qi X; Zhou H; Jia L
    Int J Biochem Cell Biol; 2018 Jan; 94():79-88. PubMed ID: 29208566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-26a-5p potentiates metastasis of human lung cancer cells by regulating ITGβ8- JAK2/STAT3 axis.
    Song Q; Liu B; Li X; Zhang Q; Cao L; Xu M; Meng Z; Wu X; Xu K
    Biochem Biophys Res Commun; 2018 Jun; 501(2):494-500. PubMed ID: 29746867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiRNA-26a promotes angiogenesis in a rat model of cerebral infarction via PI3K/AKT and MAPK/ERK pathway.
    Liang Z; Chi YJ; Lin GQ; Luo SH; Jiang QY; Chen YK
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3485-3492. PubMed ID: 29917203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-26a inhibits proliferation and migration of HaCaT keratinocytes through regulating PTEN expression.
    Yu N; Yang Y; Li X; Zhang M; Huang J; Wang X; Long X
    Gene; 2016 Dec; 594(1):117-124. PubMed ID: 27613140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scutellaria barbata D. Don inhibits 5-fluorouracil resistance in colorectal cancer by regulating PI3K/AKT pathway.
    Lin J; Feng J; Yang H; Yan Z; Li Q; Wei L; Lai Z; Jin Y; Peng J
    Oncol Rep; 2017 Oct; 38(4):2293-2300. PubMed ID: 28849113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
    Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X
    Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patrinia scabiosaefolia Inhibits Growth of 5-FU-Resistant Colorectal Carcinoma Cells via Induction of Apoptosis and Suppression of AKT Pathway.
    Huang SZ; Liu WY; Huang Y; Shen AL; Liu LY; Peng J
    Chin J Integr Med; 2019 Feb; 25(2):116-121. PubMed ID: 29948597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.